Cordex Systems Overview

  • Founded
  • 2009
Founded
  • Status
  • Private
  • Employees
  • 3
Employees
  • Latest Deal Type
  • Later Stage VC
  • Latest Deal Amount
  • $5M
Latest Deal Amount
  • Investors
  • 6

Cordex Systems General Information

Description

Manufacturer of cardiovascular diagnostic device designed to provide a significant impact on the disease lethality of patients suffering from various diseases. The company's device uses a patent-pending diagnostic tool that provides both early detection and ongoing monitoring of cardiovascular disease by measuring endothelial dysfunction, thereby enabling patients to diagnose the onset of cardiovascular disease and monitor the efficacy of prescribed treatment.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Diagnostic Equipment
Other Industries
Discovery Tools (Healthcare)
Primary Office
  • 415 Fourth Street
  • Suite 202
  • Annapolis, MD 20815
  • United States
+1 (202) 000-0000
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Cordex Systems Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Later Stage VC 09-Mar-2017 $5M 00.000 Completed Generating Revenue
3. Later Stage VC 04-Feb-2015 00.00 Cancelled Generating Revenue
2. Early Stage VC 25-Sep-2013 $155K Completed Startup
1. Seed Round 20-Feb-2013 $155K $155K Completed Startup
To view Cordex Systems’s complete valuation and funding history, request access »

Cordex Systems Patents

Cordex Systems Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
CA-2942022-A1 Method and device for detecting and assessing reactive hyperemia using segmental plethysmography Pending 11-Mar-2014 0000000000
EP-3116383-A1 Method and device for detecting and assessing reactive hyperemia using segmental plethysmography Pending 11-Mar-2014 0000000000
EP-3116383-A4 Method and device for detecting and assessing reactive hyperemia using segmental plethysmography Pending 11-Mar-2014 0000000000 0
JP-6494669-B2 Method and apparatus for detecting and evaluating reactive hyperemia using segmental plethysmography Active 11-Mar-2014 0000000000
JP-2017508583-A Method and apparatus for detecting and evaluating reactive hyperemia using segmental plethysmography Granted 11-Mar-2014 A61B5/0295 0
To view Cordex Systems’s complete patent history, request access »

Cordex Systems Executive Team (4)

Name Title Board Seat Contact Info
Kathy Magliato MD Co-Founder, Chief Executive Officer, Chief Medical Officer & Board Member
Albert Fleury III President, Chief Financial Officer and Chief Operating Officer
Michael Whitt Co-Founder
Stephen Ritterbush Ph.D Co-Founder
To view Cordex Systems’s complete executive team members history, request access »

Cordex Systems Board Members (2)

Name Representing Role Since
Enrique Posner Self Board Member 000 0000
Kathy Magliato MD Cordex Systems Co-Founder, Chief Executive Officer, Chief Medical Officer & Board Member 000 0000
To view Cordex Systems’s complete board members history, request access »

Cordex Systems Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Cordex Systems Investors (6)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
National Institutes of Health Government Minority 000 0000 000000 0
Plum Alley Investments Venture Capital Minority 000 0000 000000 0
Blue Creek Equity Partners PE/Buyout Minority 000 0000 000000 0
Environmental Protection Agency Other Minority 000 0000 000000 0
Maryland Industrial Partnerships University Minority 000 0000 000000 0
You’re viewing 5 of 6 investors. Get the full list »